AKTS Aktis Oncology, Inc.
Healthcare · Market cap: $888.3M
–
Bought and sold by quarter, last 5 years
Open-market purchases and sales by this company's insiders, in dollars, last 5 years
| Quarter | Bought | Sold |
|---|---|---|
| 2022-Q1 | $0 | $0 |
| 2022-Q2 | $0 | $0 |
| 2022-Q3 | $0 | $0 |
| 2022-Q4 | $0 | $0 |
| 2023-Q1 | $0 | $0 |
| 2023-Q2 | $0 | $0 |
| 2023-Q3 | $0 | $0 |
| 2023-Q4 | $0 | $0 |
| 2024-Q1 | $0 | $0 |
| 2024-Q2 | $0 | $0 |
| 2024-Q3 | $0 | $0 |
| 2024-Q4 | $0 | $0 |
| 2025-Q1 | $0 | $0 |
| 2025-Q2 | $0 | $0 |
| 2025-Q3 | $0 | $0 |
| 2025-Q4 | $0 | $0 |
| 2026-Q1 | $114.3M | $0 |
| 2026-Q2 | $0 | $0 |
| 2026-Q3 | $0 | $3.2M |
| 2026-Q4 | $0 | $0 |
Bought$114.3M6 buy days
Sold$3.2M5 sell days
Net insider flow+$111.1Mnet buying · 5 years
Latest trade2026-09-23Czibere Akos
| Date | Side | Insider | Role | Shares | Avg price | Value | Trades |
|---|---|---|---|---|---|---|---|
| 2026-09-23 | Sell | Czibere Akos | Other C-suite | 12,500 | $20.69 | $258.6K | 2 |
| 2026-07-20 | Sell | Herrmann Ken | Director | 4,856 | $24.56 | $119.3K | 2 |
| 2026-07-17 | Sell | Herrmann Ken | Director | 3,065 | $25.21 | $77.3K | 1 |
| 2026-07-08 | Sell | Czibere Akos | Other C-suite | 50,000 | $27.77 | $1.4M | 3 |
| 2026-07-08 | Sell | Ron-Bigger Shulamit | COO | 50,000 | $27.75 | $1.4M | 3 |
| 2026-01-12 | Buy | NODELMAN OLEG | Director | 2,222,222 | $18.00 | $40.0M | 2 |
| 2026-01-12 | Buy | EVNIN LUKE | 10% owner | 1,112,777 | $18.00 | $20.0M | 1 |
| 2026-01-12 | Buy | GADICKE ANSBERT | 10% owner | 1,112,777 | $18.00 | $20.0M | 1 |
| 2026-01-12 | Buy | Kim Helen Susan | Director | 835,000 | $18.00 | $15.0M | 2 |
| 2026-01-12 | Buy | Vida Ventures II, LLC | 10% owner | 835,000 | $18.00 | $15.0M | 2 |
| 2026-01-12 | Buy | Foley Todd | Director | 232,870 | $18.00 | $4.2M | 1 |
Who the insiders are, last 5 years
Everyone who bought or sold this company's shares on the open market in the last 5 years, biggest first.
| Insider | Role | Bought | Sold | Last trade |
|---|---|---|---|---|
| NODELMAN OLEG | Director | $40.0M | $0 | 2026-01-12 |
| EVNIN LUKE | 10% owner | $20.0M | $0 | 2026-01-12 |
| GADICKE ANSBERT | 10% owner | $20.0M | $0 | 2026-01-12 |
| Kim Helen Susan | Director | $15.0M | $0 | 2026-01-12 |
| Vida Ventures II, LLC | 10% owner | $15.0M | $0 | 2026-01-12 |
| Foley Todd | Director | $4.2M | $0 | 2026-01-12 |
| Czibere Akos | Other C-suite | $0 | $1.6M | 2026-09-23 |
| Ron-Bigger Shulamit | COO | $0 | $1.4M | 2026-07-08 |
| Herrmann Ken | Director | $0 | $196.5K | 2026-07-20 |
Past buying clusters
A cluster is a run of purchases by three or more insiders. Returns are the stock's return minus its benchmark's (IWM for small companies, SPY otherwise), from the first open after the run became a cluster. Past results, not a forecast.
| Window | Insiders | Total | Score | 21 days vs benchmark | 63 days vs benchmark | 126 days vs benchmark | Status |
|---|---|---|---|---|---|---|---|
| 2026-01-12 | 6 | $114.3M | 49 | -20.3% (-22.3% raw) | -22.4% (-21.5% raw) | 0.0% (+8.5% raw) | closed |
Yahoo Finance data, delayed, loaded through this server. Informational only; not investment advice.